G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 51.2 HKD -0.19% Market Closed
Market Cap: 52B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note

Giant Biogene Holding Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Giant Biogene Holding Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Current Liabilities
ÂĄ230.7m
CAGR 3-Years
-51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Current Liabilities
ÂĄ2.1B
CAGR 3-Years
57%
CAGR 5-Years
29%
CAGR 10-Years
26%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Other Current Liabilities
ÂĄ96m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Other Current Liabilities
ÂĄ475.8m
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Other Current Liabilities
ÂĄ611m
CAGR 3-Years
79%
CAGR 5-Years
33%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Current Liabilities
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Giant Biogene Holding Co Ltd
Glance View

Market Cap
52.6B HKD
Industry
Consumer products

In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.

Intrinsic Value
53.88 HKD
Undervaluation 5%
Intrinsic Value
Price
G

See Also

What is Giant Biogene Holding Co Ltd's Other Current Liabilities?
Other Current Liabilities
230.7m CNY

Based on the financial report for Dec 31, 2023, Giant Biogene Holding Co Ltd's Other Current Liabilities amounts to 230.7m CNY.

What is Giant Biogene Holding Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
-51%

Over the last year, the Other Current Liabilities growth was 268%. The average annual Other Current Liabilities growth rates for Giant Biogene Holding Co Ltd have been -51% over the past three years .

Back to Top